ArticleNeurology(R) neuroimmunology & neuroinflammation2017

Natalizumab-PML survivors with subsequent MS treatment: Clinico-radiologic outcome.

Elisabeth Maillart et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.